Nestle divests peanut allergy business Palforzia

  • 📰 SaltWire Network
  • ⏱ Reading Time:
  • 9 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 63%

Canada News News

Canada Canada Latest News,Canada Canada Headlines

ZURICH (Reuters) - Nestle has divested its peanut allergy treatment business Palforzia, the Swiss food company said on Monday, following its strategic ...

STORY CONTINUES BELOW THESE SALTWIRE VIDEOSZURICH - Nestle has divested its peanut allergy treatment business Palforzia, the Swiss food company said on Monday, following its strategic review of the division.

Nestle said it has offloaded Palforzia to Stallergenes Greer, a biopharmaceutical company which specializes in the diagnosis and treatment of allergies.Share story:

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 45. in CA

Canada Canada Latest News, Canada Canada Headlines